Latest Headlines

  1. Gemini Bio-Products To Distribute Nordmark Cell Therapy Reagent Products In US

    Gemini Bioproducts, LLC (“Gemini”), a portfolio company of BelHealth Investment Partners, LLC (“BelHealth”), a New York-based healthcare private equity firm, recently announced a distribution agreement with Nordmark Biochemicals, a division of Nordmark Arzneimittel GmbH & Co. KG (“Nordmark”). Launching this week, customers in the United States can now purchase Nordmark’s line of collagenase and neutral protease products directly from Gemini.

  2. SIRION Biotech Soars To New Heights: Announces 100 Percent Record Growth In 2019 And Expands US Presence

    SIRION Biotech GmbH (“SIRION”), a world leader in viral vector-based gene delivery technologies for gene and cell therapy, announced financial results for the first half of 2019.  SIRION’s viral vector technologies make breakthrough advances in cell and gene therapy possible.

  3. Facility Design Takeaways From Novartis And University Of Pennsylvania Cell Therapy Facility

    In August the Novartis Institutes for Bio-Medical Research, based in Cambridge, Massachusetts, and the University of Pennsylvania’s Perelman School of Medicine (Penn Medicine) announced they had entered into an exclusive global research and licensing agreement. Under the alliance, Penn Medicine granted Novartis an exclusive worldwide license to the technologies used in an ongoing trial of patients with chronic lymphocytic leukemia (CLL) as well as future therapies based on chimeric antigen receptor (CAR) technology developed through the collaboration.

  4. Bayer Increases Cell Therapy Presence With Acquisition Of BlueRock Therapeutics

    Bayer AG and BlueRock Therapeutics recently announced an agreement under which Bayer will fully acquire BlueRock Therapeutics, a privately held US-headquartered biotechnology company focused on developing engineered cell therapies in the fields of neurology, cardiology and immunology, using a proprietary induced pluripotent stem cell (iPSC) platform.

  5. Sartorius Stedim Biotech Launches New Services For Mammalian Cell Bank Manufacturing

    Sartorius Stedim Biotech (SSB), a leading partner of the biopharmaceutical industry, recently announced the launch of new services for mammalian cell bank manufacture under GMP conditions.

  6. Avalon GloboCare, GE Healthcare To Accelerate Bioproduction Of Cellular Medicines

    Avalon GloboCare Corp., a leading clinical-stage global developer of cell-based technologies and therapeutics, has announced that they have established a strategic partnership with GE Healthcare.

  7. IPS Provides Engineering Solutions To BWXT For The Development And Commercialization Of Diagnostic Medical Isotopes

    IPS-Integrated Project Services, ULC, a leading provider of Engineering, Procurement, Construction Administration and Validation (EPCAV) services, was selected by BWXT ITG Canada, Inc. to provide Basis of Design and Detailed Design for BWX Technologies, Inc.'s (BWXT) isotope project, specifically the expansion of their medical isotope and radiopharmaceutical facility in Ottawa, Ontario, Canada.

  8. Kite, A Gilead Company, Announces Plans For New 67,000-Square-Foot Cell Therapy Manufacturing Facility In CA; Dedicated To Viral Vectors

    Kite, a Gilead Company, recently announced plans for a new 67,000-square-foot facility in Oceanside, California, dedicated to the development and manufacturing of viral vectors, a critical starting material in the production of cell therapies.

  9. IPS To Design New Nexus Pharmaceuticals Manufacturing Facility In Wisconsin

    Nexus Pharmaceuticals Inc., a woman-owned, privately held, US-based healthcare company, announced recently an agreement with the village of Pleasant Prairie, Wisconsin to build an industry-leading sterile injectable manufacturing facility.

  10. Lupin Project Wins ENR Global Best Project Award Of Merit: Manufacturing

    ENR's Global Best Projects identifies and honors the project teams behind outstanding design and construction efforts of the past year. They received a record number of entries produces a diverse set of projects located in 20 countries that focused on safety performance, innovations, challenges, and design and construction quality - with a special emphasis on the diversity of global project teams and their collaboration.